Limerston Capital has acquired Concept Life Sciences, a leading integrated drug discovery, development and manufacturing organisation, in a carve-out from Spectris plc, through its new fund Limerston Capital Partners II, LP.  The acquisition is Limerston’s fourth platform deal in the life sciences space. The firm targets UK businesses with EBITDA of between £5 million and £15 million.    Concept Life Sciences is an established contract research organisation (CRO), primarily serving the global research and development market, with clients in the pharmaceutical and biotechnology space ranging from blue chip to virtual biotech.  Its team of around 300 accomplished scientists and over

The Riverside Company, a global private investor focused on the smaller end of the middle market, is to acquire Dastex Reinraumzubehör GmbH & Co, an independently owned cleanroom garment & consumables distributor in Europe, and Vita Verita, a leading player in the Swedish market, as a first add-on to the platform. 

Vista Equity Partners has completed its acquisition of Duck Creek Technologies a provider of property and casualty and general insurance software solutions, for $19.00 per share, in an all-cash transaction valued at approximately $2.6 billion.

Apollo Global Management is considering a bid of up to $2.78 billion to acquire Arconic, a manufacturer of lightweight metal sheeting products for the aerospace, automotive, transport, packaging, and construction sectors, according to a report by Bloomberg.

HIG Capital has acquired Synecore Limited and Meesons Futures Limited, which will now be combined with HIG’s existing portfolio companies, CPS and Classic Lifts, to form the Andwis Group, a new property focused technical services provider. 

Perwyn, a European private equity investor, has made a “substantial” investment in Datatonic, a cloud data and artificial intelligence consultancy, whose global enterprise clients include BT, Vodafone, Sky, Delivery Hero, Mulberry, and Lush.

Private equity firm TPG is considering selling its Singapore-based healthcare company TE Healthcare Partners and is seeking a valuation of almost $1 billion for the business, according to a report by the Edge.

Private equity deal value in Asia Pacific plunged 44% year-on-year to $198 billion in 2022, ending two years of record dealmaking, according to Bain & Company’s Asia Pacific Private Equity Report 2023.